-
-
NCT00231660
-
Primary Citation Trial has yet to be published
-
Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNutritional and Metabolic DiseasesEnrollment221% FemaleN/A% WhiteN/A
Product ClassAnticonvulsantsSponsor Protocol NumberTOPMAT-OBDM-002Data PartnerJohnson & JohnsonCondition StudiedObesityMean/Median Age (Years)N/A
Supporting Documentation
- Clinical Study Report Available
Additional Information
Please note: individual participant-level data are not available for this trial. Only the clinical study report is available.
Approved Data Requests Associated with this Trial
- 2024-0972 : Estimating Reliable Treatment Effects Despite Blinding Failures in Clinical Trials
- 2024-0580 : Developing approaches to accelerate clinical trials using real world data (RWD) from electronic health records (EHR)
- 2020-4276 : Psychiatric Symptoms as Adverse Events of Topiramate Therapy: Systematic Review and Meta-Analysis